Most lately, it has been identified that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://carolinex086pps6.wikilima.com/user